Citation Impact
Citing Papers
Vitamin D Deficiency and Risk of Cardiovascular Disease
2008 Standout
Protein breakdown in muscle wasting: Role of autophagy-lysosome and ubiquitin-proteasome
2013
Sirtuins as regulators of metabolism and healthspan
2012 Standout
AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
2009 StandoutNature
The promise and challenge of therapeutic genome editing
2020 StandoutNatureNobel
Protein S-nitrosylation in health and disease: a current perspective
2009
Oxidative stress, aging, and diseases
2018 Standout
MYC on the Path to Cancer
2012 Standout
Adult satellite cells and embryonic muscle progenitors have distinct genetic requirements
2009 Nature
Foreign body reaction to biomaterials
2008 Standout
Influence of Metabolism on Epigenetics and Disease
2013 StandoutNobel
Nrf2-Keap1 signaling in oxidative and reductive stress
2018 Standout
Frailty Consensus: A Call to Action
2013 Standout
MicroRNAs Involved in Molecular Circuitries Relevant for the Duchenne Muscular Dystrophy Pathogenesis Are Controlled by the Dystrophin/nNOS Pathway
2010
The AMPK signalling pathway coordinates cell growth, autophagy and metabolism
2011 Standout
GDF11 Increases with Age and Inhibits Skeletal Muscle Regeneration
2015
Regulation of chromatin by histone modifications
2011 Standout
NCoR1 Is a Conserved Physiological Modulator of Muscle Mass and Oxidative Function
2011
Sphingosine-1-Phosphate Enhances Satellite Cell Activation in Dystrophic Muscles through a S1PR2/STAT3 Signaling Pathway
2012
Autophagy regulates satellite cell ability to regenerate normal and dystrophic muscles
2016
Cell Biology of Ischemia/Reperfusion Injury
2012 Standout
Mechanisms of nuclear reprogramming by eggs and oocytes: a deterministic process?
2011 StandoutNobel
Vitamin D reduces the expression of collagen and key profibrotic factors by inducing an antifibrotic phenotype in mesenchymal multipotent cells
2008
Glucose Restriction Inhibits Skeletal Myoblast Differentiation by Activating SIRT1 through AMPK-Mediated Regulation of Nampt
2008
Epigenetics in cancer
2009 Standout
Cancer-associated cachexia
2018 Standout
A Long Noncoding RNA Controls Muscle Differentiation by Functioning as a Competing Endogenous RNA
2011 Standout
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
Current and Future Pharmacologic Treatment of Sarcopenia
2011
Body composition and sarcopenia: The next-generation of personalized oncology and pharmacology?
2018
cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action
2010 Standout
Anchor extension: a structure-guided approach to design cyclic peptides targeting enzyme active sites
2021 StandoutNobel
The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men
2008
Systems-based Discovery of Tomatidine as a Natural Small Molecule Inhibitor of Skeletal Muscle Atrophy
2014
Nuclear reprogramming in eggs
2009 StandoutNobel
Muscle wasting in disease: molecular mechanisms and promising therapies
2014
Myc-Nick: A Cytoplasmic Cleavage Product of Myc that Promotes α-Tubulin Acetylation and Cell Differentiation
2010
Light‐Controlled Histone Deacetylase (HDAC) Inhibitors: Towards Photopharmacological Chemotherapy
2015 StandoutNobel
Sarcopenia
2019 Standout
The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation
2005 Standout
Circ-ZNF609 Is a Circular RNA that Can Be Translated and Functions in Myogenesis
2017 Standout
The many roles of histone deacetylases in development and physiology: implications for disease and therapy
2008 Standout
Mechanisms of fatty acid-induced inhibition of glucose uptake.
1994 Standout
TGF-β and the TGF-β Family: Context-Dependent Roles in Cell and Tissue Physiology
2016 Standout
Epigenetic factors influencing resistance to nuclear reprogramming
2011 StandoutNobel
AKT/PKB Signaling: Navigating the Network
2017 Standout
Adipocyte differentiation from the inside out
2006 Standout
Efficiencies and Mechanisms of Nuclear Reprogramming
2010 StandoutNobel
Emerging Strategies in the Treatment of Duchenne Muscular Dystrophy
2018
Signaling pathways controlling skeletal muscle mass
2013
Importance of epigenetic mechanisms in visceral pain induced by chronic water avoidance stress
2012
Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy
2007
Cell–cell fusion
2007
Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease
2009
Nuclear reprogramming to a pluripotent state by three approaches
2010 StandoutNatureNobel
Exon 45 Skipping Through U1-snRNA Antisense Molecules Recovers the Dys-nNOS Pathway and Muscle Differentiation in Human DMD Myoblasts
2012
Redox Control of Skeletal Muscle Regeneration
2016
Oxygen Consumption and Usage During Physical Exercise: The Balance Between Oxidative Stress and ROS-Dependent Adaptive Signaling
2012
Nuclear Reprogramming in Cells
2008 StandoutScienceNobel
Acquisition and extinction of gene expression programs are separable events in heterokaryon reprogramming
2006
Xenopusoocytes reactivate muscle gene transcription in transplanted somatic nuclei independently of myogenic factors
2009 StandoutNobel
Requirement for serum response factor for skeletal muscle growth and maturation revealed by tissue-specific gene deletion in mice
2005
Treatment of Sarcopenia with Bimagrumab: Results from a Phase II, Randomized, Controlled, Proof‐of‐Concept Study
2017
Common micro‐RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia
2009
Modulation of antigen‐presenting cells by HDAC inhibitors: implications in autoimmunity and cancer
2011
Fiber Types in Mammalian Skeletal Muscles
2011 Standout
Alternative Activation of Macrophages: An Immunologic Functional Perspective
2008 Standout
Histone Deacetylase Inhibitors: Overview and Perspectives
2007
Combination therapy in combating cancer
2017 Standout
Thyroid Hormone Regulation of Metabolism
2014 Standout
Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia
2016
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
Satellite Cells and the Muscle Stem Cell Niche
2013 Standout
Histone deacetylase degradation andMEF2 activation promote the formation of slow-twitch myofibers
2007
Ribosome Biogenesis: Emerging Evidence for a Central Role in the Regulation of Skeletal Muscle Mass
2014 Standout
Cellular and molecular mechanisms of sarcopenia: the S100B perspective
2018
Mechanisms regulating skeletal muscle growth and atrophy
2013
Wnt10b Deficiency Promotes Coexpression of Myogenic and Adipogenic Programs in Myoblasts
2005
Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV
2016 Standout
Ex vivo treatment with nitric oxide increases mesoangioblast therapeutic efficacy in muscular dystrophy
2006
Works of Giulia Minetti being referenced
Histone Deacetylase Inhibitors in the Treatment of Muscular Dystrophies: Epigenetic Drugs for Genetic Diseases
2011
Deacetylase Inhibitors Increase Muscle Cell Size by Promoting Myoblast Recruitment and Fusion through Induction of Follistatin
2004
Regenerative pharmacology in the treatment of genetic diseases: The paradigm of muscular dystrophy
2008
Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors
2006
An Antibody Blocking Activin Type II Receptors Induces Strong Skeletal Muscle Hypertrophy and Protects from Atrophy
2013
Gα i2 Signaling Promotes Skeletal Muscle Hypertrophy, Myoblast Differentiation, and Muscle Regeneration
2011
Nitric oxide deficiency determines global chromatin changes in Duchenne muscular dystrophy
2009